These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38101533)

  • 21. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
    Guo F; Zhu X; Zhao Q; Huang Q
    Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
    Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
    Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
    Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
    Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
    Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
    Yang Q; Ji G; Li J
    Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
    Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
    Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
    Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling.
    Zhang J; Liu Y; Pu S; He J; Zhou C
    Breast Cancer Res Treat; 2021 Feb; 186(1):247-258. PubMed ID: 33423159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway.
    Huang HM; He XH; Huang XY; Wang GY; Xia QX; Du ZP; Zhang YF
    Cell Commun Signal; 2022 Mar; 20(1):35. PubMed ID: 35305679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells.
    Deng W; Wang Y; Gu L; Duan B; Cui J; Zhang Y; Chen Y; Sun S; Dong J; Du J
    BMC Cancer; 2016 Jul; 16():489. PubMed ID: 27430308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.
    Zhang C; Xu B; Lu S; Zhao Y; Liu P
    Mol Cancer; 2017 May; 16(1):90. PubMed ID: 28490334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.